Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Effect of infarcts on dementia in the Baltimore longitudinal study of aging.

Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ.

Ann Neurol. 2008 Aug;64(2):168-76. doi: 10.1002/ana.21413.

2.

Current and future uses of neuroimaging for cognitively impaired patients.

Small GW, Bookheimer SY, Thompson PM, Cole GM, Huang SC, Kepe V, Barrio JR.

Lancet Neurol. 2008 Feb;7(2):161-72. doi: 10.1016/S1474-4422(08)70019-X. Review.

3.

Prevalence of dementia in the United States: the aging, demographics, and memory study.

Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB.

Neuroepidemiology. 2007;29(1-2):125-32.

4.

Education and dementia: what lies behind the association?

Ngandu T, von Strauss E, Helkala EL, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M.

Neurology. 2007 Oct 2;69(14):1442-50.

PMID:
17909157
5.

Traumatic brain injury and Alzheimer's disease: a review.

Van Den Heuvel C, Thornton E, Vink R.

Prog Brain Res. 2007;161:303-16. Review.

PMID:
17618986
6.

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P.

Lancet Neurol. 2007 Aug;6(8):734-46. Review.

PMID:
17616482
7.

Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.

Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, Kryscio RJ.

Am J Epidemiol. 2007 Jun 1;165(11):1231-8.

8.

Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.

Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH.

Neurology. 2007 Jan 23;68(4):288-91.

PMID:
17242334
9.

Mild cognitive impairment: long-term course of four clinical subtypes.

Busse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG.

Neurology. 2006 Dec 26;67(12):2176-85.

PMID:
17190940
10.

PET of brain amyloid and tau in mild cognitive impairment.

Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.

N Engl J Med. 2006 Dec 21;355(25):2652-63.

11.

Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.

Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.

Dement Geriatr Cogn Disord. 2006;22(1):73-82.

PMID:
16699282
12.

Neuropathologic features of amnestic mild cognitive impairment.

Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E.

Arch Neurol. 2006 May;63(5):665-72.

PMID:
16682536
13.

Risk factors for transitions from normal to mild cognitive impairment and dementia.

Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR.

Neurology. 2006 Mar 28;66(6):828-32.

PMID:
16567698
15.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
16.

APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.

Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L.

Arch Neurol. 2004 Dec;61(12):1930-4. Erratum in: Arch Neurol. 2005 Mar;62(3):453.

PMID:
15596614
17.

In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

Verhoeff NP, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, Kung HF, Kung MP, Houle S.

Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):584-95.

PMID:
15545326
18.

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC.

J Intern Med. 2004 Sep;256(3):240-6. Review.

19.

Mild cognitive impairment as a diagnostic entity.

Petersen RC.

J Intern Med. 2004 Sep;256(3):183-94. Review.

20.

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J.

Neurology. 2004 Jun 8;62(11):1977-83.

PMID:
15184600
Items per page

Supplemental Content

Support Center